Pediatrics

A table showing recommended immunization schedules for child and adolescent patients.

Pharmacy Times spoke with Suzanne Soliman, PharmD, BCMAS, about how pharmacists can prepare their patients for the back-to-school season amid the COVID-19 pandemic and the upcoming flu season.

Pharmacy Times will continue to bring readers the latest information on COVID-19 developments, in a variety of formats.

Risdiplam is the first at-home, orally administered treatment for spinal muscular atrophy in adults and children aged 2 months and older.

How did switching from name brand to generic cause a child’s death?

Staying up-to-date on immunizations is crucial to prevent outbreaks of vaccine-preventable diseases.

CPP is a rare disease defined as the onset of puberty before age 8 years in girls and before age 9 years in boys.

Efinaconazole was first approved by the FDA in June 2014 for patients 18 and older.

The kinase inhibitor selumetinib was approved for the treatment of pediatric patients aged 2 years and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

This medication inhaler is indicated for the treatment or prevention of bronchospasm in patients ages 4 years and older who have reversible obstructive airway disease.

Community pharmacy antibiotic dispensing data were obtained from the New Zealand Pharmaceutical Collection database for children whose parents consented to external data linkage.

Fidaxomicin is a macrolide antibacterial medicine indicated to be used to treat infections that are proven or strongly suspected to be caused by C. difficile.

Why is a 15-year-old boy being prescribed anastrozole?

Liraglutide is the first noninsulin drug approved to treat T2D in pediatric patients since metformin was approved for pediatric use in 2000, according to the FDA.

VTE can include deep vein thrombosis and pulmonary embolism, which can lead to death.

Although the prevalence of LEMS in children is not known, the overall prevalence is estimated to be 3 per million individuals worldwide, according to the FDA.

Novo Nordisk is seeking approval for fast-acting insulin aspart (Fiasp) as a new mealtime insulin for children and adolescents with type 1 diabetes.

Officials with the FDA have approved romiplostim (NPLATE, Amgen) for the treatment of immune thrombocytopenia (ITP) in pediatric patients aged 1 year and older.

Officials with the FDA have approved Jazz Pharmaceuticals' Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness (EDS) in pediatric patients aged 7 to 17 years with narcolepsy.

The FDA has approved dupilumab (Dupixent®, Regeneron and Sanofi) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.

The FDA has approved sarecycline (Seysara, Almirall) for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients aged 9 years and older.

The FDA has expanded the indication of the antiepileptic drug perampanel (FYCOMPA®, Eisai) CIII for monotherapy and adjunctive use in pediatric patients aged 4 years and older for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures.

One lot of Children’s Advil® Suspension, Bubble Gum Flavored Liquid bottles (4 fluid ounces) is being voluntarily recalled by Pfizer Consumer Healthcare

A young patient, aged 11 months, suffered a stroke after being infected with the varicella zoster virus, commonly known as chickenpox.

Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.

The Archives of Disease in Childhood, Education and Practice Edition has published a manuscript that describes a structured approach to chronic cough in children.

Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.

The utility of determining a patient's asthma phenotype is a current research priority, since various phenotypes seem to respond differently to interventions and medication.

Clinicians who work with adolescents who have asthma report numerous adherence barriers.

Children may have to skip school, be admitted to the hospital, and occasionally, children die from asthma attacks. That's a clear call for better intervention on the part of healthcare providers.